AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

24.26 USD
-0.34 (-1.38%)
Last: Mar 9, 2026, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Taking everything into account, AXR scores 7 out of 10 in our fundamental rating. AXR was compared to 62 industry peers in the Real Estate Management & Development industry. AXR gets an excellent profitability rating and is at the same time showing great financial health properties. AXR is not valued too expensively and it also shows a decent growth rate. With these ratings, AXR could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. AXR Profitability Analysis

1.1 Basic Checks

  • AXR had positive earnings in the past year.
  • In the past year AXR had a positive cash flow from operations.
  • In the past 5 years AXR has always been profitable.
  • AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.49%, AXR belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 7.72%, AXR is in the better half of the industry, outperforming 79.03% of the companies in the same industry.
  • AXR has a Return On Invested Capital of 7.10%. This is amongst the best in the industry. AXR outperforms 83.87% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AXR is above the industry average of 5.52%.
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROIC 7.1%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • AXR's Profit Margin of 22.86% is amongst the best of the industry. AXR outperforms 91.94% of its industry peers.
  • In the last couple of years the Profit Margin of AXR has declined.
  • Looking at the Operating Margin, with a value of 24.45%, AXR belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AXR has declined.
  • With a decent Gross Margin value of 41.05%, AXR is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXR is destroying value.
  • AXR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AXR has less shares outstanding
  • AXR has a better debt/assets ratio than last year.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • AXR has an Altman-Z score of 21.64. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
  • AXR has a Altman-Z score of 21.64. This is amongst the best in the industry. AXR outperforms 96.77% of its industry peers.
  • The Debt to FCF ratio of AXR is 0.01, which is an excellent value as it means it would take AXR, only 0.01 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AXR (0.01) is better than 93.55% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that AXR is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.00, AXR belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 21.64
ROIC/WACC0.81
WACC8.79%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • AXR has a Current Ratio of 27.73. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 27.73, AXR belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
  • A Quick Ratio of 10.93 indicates that AXR has no problem at all paying its short term obligations.
  • The Quick ratio of AXR (10.93) is better than 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 27.73
Quick Ratio 10.93
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • AXR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.00%.
  • AXR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.33% yearly.
  • The Revenue for AXR has decreased by -27.32% in the past year. This is quite bad
  • Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.71% on average over the next years.
  • The Revenue is expected to grow by 11.91% on average over the next years. This is quite good.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.38, AXR is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 83.87% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, AXR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.49, the valuation of AXR can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, AXR is valued cheaper than 93.55% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.65. AXR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.38
Fwd PE 11.49
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AXR is valued cheaper than 98.39% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AXR is valued a bit cheaper than 69.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.86
EV/EBITDA 7.49
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • AXR has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as AXR's earnings are expected to decrease with -2.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (3/9/2026, 8:04:00 PM)

24.26

-0.34 (-1.38%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)12-12
Earnings (Next)03-13
Inst Owners44.69%
Inst Owner Change-0.97%
Ins Owners45.64%
Ins Owner Change2.08%
Market Cap128.82M
Revenue(TTM)45.95M
Net Income(TTM)10.50M
Analysts80
Price Target23.46 (-3.3%)
Short Float %0.91%
Short Ratio4.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.09%
Min EPS beat(2)-50.49%
Max EPS beat(2)126.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)27.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 12.38
Fwd PE 11.49
P/S 2.8
P/FCF 28.86
P/OCF 25.73
P/B 0.95
P/tB 0.95
EV/EBITDA 7.49
EPS(TTM)1.96
EY8.08%
EPS(NY)2.11
Fwd EY8.7%
FCF(TTM)0.84
FCFY3.46%
OCF(TTM)0.94
OCFY3.89%
SpS8.65
BVpS25.62
TBVpS25.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.61
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROCE 8.26%
ROIC 7.1%
ROICexc 10.57%
ROICexgc 10.61%
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
FCFM 9.71%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 223.46%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 43.61%
Profit Quality 42.5%
Current Ratio 27.73
Quick Ratio 10.93
Altman-Z 21.64
F-Score5
WACC8.79%
ROIC/WACC0.81
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y-11.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y-50.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y-45.53%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 6 / 10 to AMREP CORP (AXR). This can be considered as Fairly Valued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 7 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.